Is Dialysis a Test Case of Medicare for All? (Ep. 457)

Kidney failure is such a catastrophic (and expensive) disease that Medicare covers treatment for anyone, regardless of age. Since Medicare reimbursement rates are fairly low, the dialysis industry had to find a way to tweak the system if they wanted to make big profits. They succeeded.

How to Fix the Hot Mess of U.S. Healthcare (Ep. 456)

Medicine has evolved from a calling into an industry, adept at dispensing procedures and pills (and gigantic bills), but less good at actual health. Most reformers call for big, bold action. What happens if, instead, you think small?

Policymaking Is Not a Science (Yet) (Ep. 405 Rebroadcast)

Why do so many promising solutions — in education, medicine, criminal justice, etc. — fail to scale up into great policy? And can a new breed of “implementation scientists” crack the code? Listen and subscribe to our podcast at Apple Podcasts, Stitcher, or elsewhere. Below is a transcript of the episode, edited for readability. For more information on […]

Are You Ready for a Fresh Start? (Ep. 455)

Behavioral scientists have been exploring if — and when — a psychological reset can lead to lasting change. We survey evidence from the London Underground, Major League Baseball, and New Year’s resolutions; we look at accidental fresh starts, forced fresh starts, and fresh starts that backfire. And we wonder: will the pandemic’s end provide the biggest fresh start ever?

Should Traffic Lights Be Abolished? (Ep. 454)

Americans are so accustomed to the standard intersection that we rarely consider how dangerous it can be — as well as costly, time-wasting, and polluting. Is it time to embrace the lowly, lovely roundabout?

A Rescue Plan for Black America (Ep. 453)

New York Times columnist Charles Blow argues that white supremacy in America will never fully recede, and that it’s time for Black people to do something radical about it. In The Devil You Know: A Black Power Manifesto, he urges a “reverse migration” to the South to consolidate political power and create a region where it’s safe to be Black. (This is an episode of the Freakonomics Radio Book Club.)

Am I Boring You? (Ep. 225 Rebroadcast)

Researchers are trying to figure out who gets bored — and why — and what it means for ourselves and the economy. But maybe there’s an upside to boredom?

Jeff Immelt Knows He Let You Down (Ep. 452)

Not so long ago, G.E. was the most valuable company in the world, a conglomerate that included everything from light bulbs and jet engines to financial services and The Apprentice. Now it’s selling off body parts to survive. What does the C.E.O. who presided over the decline have to say for himself?

Can I Ask You a Ridiculously Personal Question? (Ep. 451)

Listen and subscribe to our podcast at Apple Podcasts, Stitcher, or elsewhere. Below is a transcript of the episode, edited for readability. For more information on the people and ideas in the episode, see the links at the bottom of this post.

How to Fix the Incentives in Cancer Research (Ep. 449)

For all the progress made in fighting cancer, it still kills 10 million people a year, and some types remain especially hard to detect and treat. Pancreatic cancer, for instance, is nearly always fatal. A new clinical-trial platform could change that by aligning institutions that typically compete against one another.